Showing results (51-60 of 125) with videos related to
Sort By:
Pageof 13
Schweizerische Medizinische Wochenschrift|September 17, 1977
[Hypoglycemic sulfonylurea metabolites: clinical interest. Experiences with glibenclamide in the rat]H Samimi, L Loutan, L Balant, et al.Schweizerische Medizinische Wochenschrift|November 11, 1978
[Metabolites of hypoglycemic sulfonylureas in kidney failure. Experience with glibenclamide]L Loutan, H Samimi, L Balant, et al.Annales De Chirurgie Plastique Et Esthetique|April 3, 1999
[Falciform anemia and Plasmodium falciparum malaria: a threat to flap survival?]S Mariéthoz, B Pittet, L Loutan, et al.Clinical Microbiology Reviews|January 18, 2005
Options for field diagnosis of human african trypanosomiasisFrançois Chappuis, Louis Loutan, Pere Simarro, et al.Vaccine|February 20, 2007
High immunogenicity of delayed third dose of hepatitis B vaccine in travellersYves Jackson, François Chappuis, Nathalie Mezger, et al.Revue Medicale Suisse|June 6, 2012
[Rickettsial diseases in Switzerland, update for the general practitioner]G Eperon, O Péter, C Socolovschi, et al.Journal of Travel Medicine|November 26, 2009
Health risks and risk-taking behaviors among International Committee of the Red Cross (ICRC) expatriates returning from humanitarian missionsAtti-La Dahlgren, Lisa Deroo, Jacqueline Avril, et al.Revue Medicale Suisse|June 14, 2006
[Imported malaria in Geneva: 1998-2004]L Bochatay, P Sudre, F Chappuis, et al.Travel Medicine and Infectious Disease|November 14, 2006
Hepatitis A vaccines and the elderlyBlaise Genton, Valérie D'Acremont, Hans-Jacob Furrer, et al.Journal of Travel Medicine|November 27, 1999
Tolerance and immunogenicity of the simultaneous administration of virosome hepatitis A and yellow fever vaccinesP A Bovier, B Althaus, R Glueck, et al.Pageof 13